Healthcare
Live Price
Offline$0.0015
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 248 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Indigenous Bloom Hemp Corp. (VRTHF) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +54.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +54.0%, free cash flow -4213.3% with operating margin 0.0% and ROIC 25.2%. Stock Foundry combines VRTHF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VRTHF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VRTHF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VRTHF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$10.8M
+9.0% YoY
Free Cash Flow
-$5.5M
-330.4% YoY
Revenue Growth
+0.0%
EPS Growth
+54.0%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
CAD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -176K | -245 | -383 | -10K | -15K |
| Operating Income | -418K | -271K | -2M | -4M | -10M |
| EBITDA | -458K | -320K | -2M | -12M | -11M |
| Net Income | -2M | -489K | -2M | -12M | -11M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CAD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Cash & Equivalents | 66K | 481 | 9K | 20K | 2M |
| Total Assets | 760K | 730 | 15K | 758K | 4M |
| Total Liabilities | 3M | 1M | 897K | 1M | 196K |
| Shareholder Equity | -2M | -498K | -881K | -461K | 4M |
| Total Debt | 708K | 69K | 288 | 0 | 0 |
| Net Debt | 642K | 68K | -9K | -20K | -2M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
5M
-340.3% YoY
Capital Expenditures
9K
+71.6% YoY
Free Cash Flow
5M
-330.4% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
155.4%
Debt / Equity
-0.29x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.